Los resultados varan pero nunca son permanentes, cada persona necesita un mantenimiento despus de varias semanas dependiendo de muchos factores
Over the past few years, due to both appropriate and inappropriate use, the demand for and use of GLP-1 and GIP/GLP-1 receptor agonists have increased substantially, leaving drug manufacturers struggling to keep their supply sufficient to meet these increased needs
Retatrutide is an investigational compound that is not FDA-approved, and PlexusDx does not sell, distribute, or prescribe Retatrutide or any other investigational peptide in this category
Pricing and Access to Semaglutide at PlexusDx PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan, with transparent, flat pricing across all commitment tiers